# US 2015/0147758 A1 · DOT1 Histone Methyltransferases as a Target for Identifying Therapeutic Agents for Leukemia

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0147758 A1
- Document ID: US20150147758A1
- Status: Published application
- Kind: A1
- Application number: 14/525,783
- Filed: 2014-10-28
- Published: 2015-05-28
- Earliest claimed: 2003-06-13
- Assignees: The University of North Carolina at Chapel Hill
- Applicants: The University of North Carolina at Chapel Hill
- Inventors: Yi ZHANG; Qin FENG; Yuki OKADA; Guoliang XU
- Web page: https://patentgrep.com/patent/US20150147758A1

## CPC

- C12Q 1/6886: for cancer (immunoassay for cancer G01N33/575)
- C07H 21/04: with deoxyribosyl as saccharide radical
- C12N 9/1007: {Methyltransferases (general) (2.1.1.)}
- C12Q 2600/118: Prognosis of disease development
- C12Q 2600/136: Screening for pharmacological compounds
- C12Q 2600/154: Methylation markers
- G01N 33/53: Immunoassay; Biospecific binding assay; Materials therefor
- G01N 33/6893: {related to diseases not provided for elsewhere}
- G01N 2440/12: alkylation, e.g. methylation, (iso-)prenylation, farnesylation
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present invention provides polypeptides with histone H3 lysine 79 methyltransferase activity as well as nucleic acids encoding the same. Also provided are methods of using the polypeptides and nucleic acids of the invention in screening assays to identify compounds of interest. Further provided are diagnostic methods for leukemia and prognostic methods to predict the course of the disease in a subject.

## Claims

### Claim at position 1

1-46. (canceled)

### Claim 47

A method of diagnosing whether a subject has or is at risk for developing leukemia and/or determining the prognosis for the course of the disease, comprising:
obtaining a biological sample comprising nucleosomes from a subject;
adding to the biological sample an antibody that binds to a methylated histone H3 lysine 79 (H3-K79);
detecting the level of H3-K79 methylation associated with the HoxA9 gene;
wherein an elevation in HoxA9-associated H3-K79 methylation in the biological sample as compared with the level of HoxA9-associated H3-K79 methylation in a non-leukemic biological sample is diagnostic that the subject has or is at risk of developing leukemia and/or is prognostic of the course of the disease in the subject.

### Claim 48 (depends on 47)

The method of claim 47, wherein the biological sample is a cell or tissue sample.

### Claim 49 (depends on 48)

The method of claim 48, wherein the biological sample is a B cell sample or bone marrow sample.

### Claim 50 (depends on 47)

The method of claim 47, wherein the biological sample is a nucleosome preparation.

### Claim 51 (depends on 47)

The method of claim 47, wherein the method further comprises detecting the level of histone H3 lysine 4 methylation associated with the HoxA9 gene.
